ChAdOx1 nCoV-19疫苗接种后疫苗后脑炎病例系列
The global SARS-CoV-2 pandemic has contributed to more than 163 million confirmed infections and 3.3 million deaths worldwide. The severity of the pandemic has led to an unprecedented effort to develop multiple effective vaccines.…
要点
- 接种ChAdOx1 nCoV-19后出现脑炎症状需考虑疫苗后脑炎可能。
- 病例符合可能的自身免疫性脑炎诊断标准,皮质类固醇治疗有效。
核心结论
- ChAdOx1 nCoV-19疫苗接种后疫苗后脑炎并发症仍非常罕见,但需及时诊断和适当治疗。
研究设计与样本
- 病例系列研究,报告与ChAdOx1 nCoV-19疫苗接种时间相关的疫苗后脑炎病例。
主要发现
- 患者符合可能的自身免疫性脑炎诊断标准。
- 患者对皮质类固醇免疫抑制治疗反应良好。
关键数值与推荐
- 诊断符合可能的自身免疫性脑炎标准。
临床怎么用
- 接种ChAdOx1 nCoV-19后出现脑炎表现时应考虑本病并及时诊治。
- 皮质类固醇免疫抑制治疗可用于本病患者。
局限性
- 需要大型观察性流行病学研究汇总数据验证因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The global SARS-CoV-2 pandemic has contributed to more than 163 million confirmed infections and 3.3 million deaths worldwide. The severity of the pandemic has led to an unprecedented effort to develop multiple effective vaccines. Due to excellent safety and efficacy data from clinical trials, several vaccines were approved. We report a case series of postvaccinal encephalitis in temporal correlation to vaccination with ChAdOx1 nCov-19. The diagnostic criteria for possible autoimmune encephalitis were fulfilled. Our patients responded well to immunosuppressive therapy with corticosteroids. The incidence has been estimated to be approximately 8 per 10 million vaccine doses. Complication of postvaccinal encephalitis after ChAdOx1 nCoV-19 vaccination still appear to be very rare, but need to be diagnosed and treated adequately. Large pooled data from observational epidemiologic studies are necessary to verify causality. ANN NEUROL 2021;90:506-511.
引用
- Zuhorn F, Graf T, Klingebiel R, et al. Postvaccinal Encephalitis after ChAdOx1 nCov-19. Ann Neurol. 2021. PMID: 34324214. doi:10.1002/ana.26182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。